Skip to content
LexBuild

Public Hearing Before a Public Advisory Committee; Examination of Administrative Record and Other Advisory Committee Records; Withdrawal

---
identifier: "/us/fr/01-9950"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Public Hearing Before a Public Advisory Committee; Examination of Administrative Record and Other Advisory Committee Records; Withdrawal"
title_number: 0
title_name: "Federal Register"
section_number: "01-9950"
section_name: "Public Hearing Before a Public Advisory Committee; Examination of Administrative Record and Other Advisory Committee Records; Withdrawal"
positive_law: false
currency: "2001-04-23"
last_updated: "2001-04-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-9950"
document_type: "rule"
publication_date: "2001-04-23"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 14"
fr_citation: "66 FR 20401"
fr_volume: 66
docket_ids:
  - "Docket No. 00N-1634"
fr_action: "Direct final rule; withdrawal."
---

#  Public Hearing Before a Public Advisory Committee; Examination of Administrative Record and Other Advisory Committee Records; Withdrawal

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Direct final rule; withdrawal.

**SUMMARY:**

The Food and Drug Administration (FDA) published in the *Federal Register* of January 8, 2001, a proposed rule (66 FR 1276) and a direct final rule (66 FR 1257) to amend FDA regulations governing the public disclosure of written information for consideration by an advisory committee at an advisory committee meeting. The comment period closed March 26, 2001. FDA is withdrawing the direct final rule because the agency received significant adverse comment.

**DATES:**

The direct final rule published in the *Federal Register* of January 8, 2001 (66 FR 1257), is withdrawn as of April 23, 2001.

**FOR FURTHER INFORMATION CONTACT:**

Andrea C. Masciale, Center for Drug Evaluation and Research (HFD-7), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-594-2041.

Therefore, under the Federal Food, Drug, and Cosmetic Act, and under the authority delegated to the Commissioner of Food and Drugs, the direct final rule published in the *Federal Register* of January 8, 2001 (66 FR 1257), is withdrawn.

Dated: April 17, 2001.

Ann M. Witt,

Acting Associate Commissioner for Policy.